NANOBIOTIX to Participate in Jefferies London Healthcare Conference

Core Insights - Nanobiotix is a late-stage clinical biotechnology company focused on pioneering nanotherapeutic approaches for cancer and other major diseases [1][2][3] - The company will participate in a fireside chat at the Jefferies London Healthcare Conference on November 17, 2025, featuring CEO Laurent Levy and CFO Bart van Rhijn [1] - Nanobiotix is headquartered in Paris, France, and is listed on Euronext Paris and Nasdaq, with subsidiaries in Cambridge, Massachusetts [3] Company Overview - Nanobiotix was incorporated in 2003 and has been listed on Euronext Paris since 2012 and on Nasdaq since December 2020 [3] - The company holds over 25 patent families related to three nanotechnology platforms, which have applications in oncology, bioavailability and biodistribution, and central nervous system disorders [3] Upcoming Events - The fireside chat will be held on November 17, 2025, at 3pm GMT / 10am ET / 4pm CET, and will be webcast live [1] - A replay of the webcast will be available after the event [1]